7.7.2021 16:16:52 CEST | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state

Over the past year, under the leadership of Espen Kvale, ABT has developed and recently launched more than 30 new natural skincare products to the market. As ABT moves from a development and production phase to a commercial phase with more focus on sales and distribution, Håvard Lindstrøm takes over the role as CEO. He has held the position Head of Business Development since August 2020. Lindstrøm has more than 24 years experience from sales and distribution, and has a Master in marketing management from BI/NMH Norwegian Business School.  

Espen Kvale will strengthen the company’s focus on on the company's research and development activities, as well as sales and distribution activities. Kvale assumes the role as COO.

* * *

For further information, please contact chairman of the board Edvard Cock mobile phone 0047 415 04 004 or CEO Håvard Lindstrøm mobile phone 0047 941 32 288.

Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skincare products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skincare products developed by partners towards consumers and professional users. ABT's focus on commercialization and development of natural ingredients and natural skincare products has been, and will continue to be, an important part of the Company's strategy going forward. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange.

 

This information is such that Aqua Bio Technology ASA is required to disclose in accordance with the EU Market Abuse Regulation, and is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

 

Disclosure regulation

This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.

Contacts

  • Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no

About Aqua Bio Technology ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

Attachments

  • Download announcement as PDF.pdf

© NTB Norway, source NTB English Regulatory Releases